EPS Bio Technology (ROCO:4183) Total Assets: NT$533.2 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4183 EPS Bio Technology Corp ROCO:4183
63 GF Score
Price NT$14.80
GF Value NT$22.94
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is EPS Bio Technology Total Assets?

EPS Bio Technology ROCO:4183 63 Total Assets is NT$533.2 Mil as of Dec. 2025. GuruFocus rates ROCO:4183 with a GF Score™ of 63/100 and a GF Value™ of NT$22.94 (Significantly Undervalued). The stock has 2 warning signs investors should review.

EPS Bio Technology's Total Assets for the quarter that ended in Dec. 2025 was NT$533.2 Mil.

During the past 12 months, EPS Bio Technology's average Total Assets Growth Rate was -0.70% per year. During the past 3 years, the average Total Assets Growth Rate was 5.50% per year. During the past 5 years, the average Total Assets Growth Rate was 4.30% per year. During the past 10 years, the average Total Assets Growth Rate was 7.60% per year.

During the past 13 years, EPS Bio Technology's highest 3-Year average Total Assets Growth Rate was 18.20%. The lowest was -6.70%. And the median was 2.35%.

Total Assets is connected with ROA %. EPS Bio Technology's annualized ROA % for the quarter that ended in Dec. 2025 was -1.92%. Total Assets is also linked to Revenue through Asset Turnover. EPS Bio Technology's Asset Turnover for the quarter that ended in Dec. 2025 was 0.23.

EPS Bio Technology  (ROCO:4183) Total Assets Explanation

Total Assets is connected with ROA %.

EPS Bio Technology's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-10.152/( (524.484+533.247)/ 2 )
=-10.152/528.8655
=-1.92 %

Note: The Net Income data used here is four times the quarterly (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

EPS Bio Technology's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=119.21/( (524.484+533.247)/ 2 )
=119.21/528.8655
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

EPS Bio Technology Total Assets Related Terms

EPS Bio Technology Total Assets Historical Data

* Premium members only.

The historical data trend for EPS Bio Technology's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EPS Bio Technology Total Assets Chart

EPS Bio Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 577.45 527.76 543.16 541.90 533.25

EPS Bio Technology Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 541.90 550.19 543.72 524.48 533.25
ROCO:4183
63GF Score
EPS Bio Technology Corp ROCO:4183
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EPS Bio Technology Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

EPS Bio Technology's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=281.106+252.141
=533.2

EPS Bio Technology's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=281.106+252.141
=533.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of NT$533.2 Mil mean?
EPS Bio Technology (ROCO:4183) has a Total Assets of NT$533.2 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on EPS Bio Technology and its competitors.
Is EPS Bio Technology's Total Assets too high?
EPS Bio Technology's current Total Assets is NT$533.2 Mil. Overall, EPS Bio Technology has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EPS Bio Technology's Total Assets compare to ABT and SYK?
EPS Bio Technology's Total Assets of NT$533.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on EPS Bio Technology and its competitors. EPS Bio Technology's current Total Assets is NT$533.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EPS Bio Technology stock overvalued right now?
Based on GuruFocus' analysis, EPS Bio Technology (ROCO:4183) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$22.94, compared to a current price of NT$14.80 — trading 35.5% below its estimated fair value. The current Total Assets is NT$533.2 Mil. EPS Bio Technology's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For EPS Bio Technology (ROCO:4183), the current Total Assets is NT$533.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EPS Bio Technology (ROCO:4183) Overvalued in 2026?

Based on GuruFocus' analysis, EPS Bio Technology stock appears to be undervalued. The current stock price of NT$14.80 is trading 35.5% below its estimated GF Value™ of NT$22.94. GuruFocus considers EPS Bio Technology to be Significantly Undervalued.

Key valuation signals for ROCO:4183:

  • Total Assets: NT$533.2 Mil
  • GF Value™: NT$22.94 vs. price of NT$14.80 (35.5% below fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the ROCO:4183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EPS Bio Technology Business Description

Address No. 8, R&D 3rd Road, Hsinchu Science Park, Hsinchu, TWN, 30076
EPS Bio Technology Corp operates in medical equipment manufacturing, international trade, intellectual property, and research, design, development, manufacture and sale of blood glucose measuring system and cirrhosis testing system. Its products include Test sheet and Glucose machine. Geographically it operates in Germany, Iran, Kingdom of Saudi Arabia, Switzerland, Las Vegas, and Others with majority of the revenue deriving from Germany.
63GF Score

Get the complete analysis for ROCO:4183

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$14.80
Price
NT$22.94
GF Value